| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4742 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009545731-A |
| titleOfInvention |
Use of NNMT as a marker for lung cancer |
| abstract |
The present invention relates to the assessment of lung cancer. The present invention discloses the use of the protein NNMT in the assessment of lung cancer. The present invention also relates to a method for evaluating lung cancer by measuring NNMT in a liquid sample derived from an individual in vitro. Measurement of NNMT can be used, for example, in tracking patients with early detection lung cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014509740-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014208156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014208156-A1 |
| priorityDate |
2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |